Newly identified bacterial protein helps design cancer drug delivery system
Researchers have identified a previously unknown bacterial protein, the unique structure of which acts as an actin homolog that can be used to design protein nanoparticles for the targeted delivery of anticancer drugs to tumors.
Registered users, subscribers or members - SIGN IN
To continue reading this article
Membership
Included as a benefit
Members of Applied Microbiology International have unlimited access to The Microbiologist as a benefit of membership. Just sign in with your usual membership credentials.
Find out more about how to join.
Register
FREE
Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy more free content each month.
Subscribe
3.75 per month / £35 annually
Get unlimited access to The Microbiologist.